Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design for Several Medicines from Merck

Merck appreciates the U.S. FDA’s recognition of our efforts to create new standardized product packaging for several of our medicines .

These changes to the packaging of several medicines were made by Merck as a result of comprehensive research conducted directly with pharmacists and pharmacy technicians to understand how the company could help them to further support the accuracy of medication dispensing within the pharmacy.

“Efforts such as this are a part of Merck’s overall commitment to help people be well,” said Michael Rosenblatt, M.D., chief medical officer for Merck. “We look forward to continuing to work with regulatory agencies and healthcare professionals to implement this new design and help bring the best possible care to patients.”

About Merck
Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit